share_log

阳光诺和(688621.SH):减重及降糖类多肽项目已有多个药学及临床研究服务订单

Sunshine Nuohe (688621.SH): multiple peptide projects for weight loss and blood sugar reduction have received multiple pharmaceutical and clinical research service orders.

Gelonghui Finance ·  Aug 6 05:45

On August 6, Gelon Hui reported that Sunshine Nuohe (688621.SH) has received multiple pharmaceutical and clinical research service orders for its weight loss and hypoglycemic polypeptide project. Currently, the company has accepted the commission from Brightgene Bio-Medical Technology Co. Ltd. for the under-research BGM0504 injection, which is mainly used for the indications of hypoglycemia and weight loss and has entered clinical phase III trials.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment